🇺🇸 FDA
Patent

US 8987454

Azaindoles useful as inhibitors of JAK and other protein kinases

granted A61KA61K31/437A61K31/444

Quick answer

US patent 8987454 (Azaindoles useful as inhibitors of JAK and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/496, A61K31/506